Related Experiment Videos
Advances in diabetic management: implications for anesthesia
Zulfiqar Ahmed1, Charles H Lockhart, Molly Weiner
1*Children's Hospital of Michigan, Detroit, Michigan; †Barbara Davis Center for Childhood Diabetes; ‡Department of Endocrinology, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center; and ¶Department of Anesthesiology, The Children's Hospital, University of Colorado Health Sciences Center, Denver, Colorado.
Anesthesia and Analgesia
|February 25, 2005
Summary
Advances in Type I diabetes mellitus management, including new insulin delivery systems and improved insulins, are transforming perioperative care for diabetic patients. An artificial pancreas is also nearing availability.
Area of Science:
- Endocrinology
- Pharmacology
- Medical Technology
Background:
- Significant advancements in Type I diabetes mellitus (T1DM) management over the last two decades.
- Development of novel insulin delivery systems and more stable insulin formulations.
- Emergence of artificial pancreas technology on the horizon.
Purpose of the Study:
- To review the recent progress in T1DM management.
- To highlight the impact of these advancements on perioperative care for diabetic patients.
Main Methods:
- Review of recent literature and technological developments in T1DM management.
- Analysis of the implications for surgical and anesthetic care.
Main Results:
- Introduction of continuous subcutaneous insulin pumps and improved insulin preparations.
- Enhanced understanding of insulin pharmacokinetics and pharmacodynamics.
- Significant improvements in the perioperative management of diabetic individuals.
Conclusions:
- Recent innovations in T1DM treatment have substantially improved patient outcomes.
- These advancements are critical for optimizing the perioperative care of patients with diabetes.